BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Promus Element Plus Platinum Chromium Stent System regulatory update

FDA approved Boston Scientific's Promus Element Plus Platinum Chromium Stent System to treat coronary artery disease (CAD). The company said it will immediately launch the drug-eluting coronary platinum chromium...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >